Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity

Blood

Volumn 121, Issue 9, 2013, Pages 1651-1662

  Rogers, Stephen C ^a,b   Ross, Jerlinda G C ^a,b   D'Avignon, Andre ^c   Gibbons, Lindsey B ^a,b   Gazit, Vered ^a,b   Hassan, Mojibade N ^a,b   McLaughlin, Dylan ^a,b   Griffin, Sherraine ^b   Neumayr, Tara ^a   DeBaun, Malcolm ^a,b   DeBaun, Michael R ^b   Doctor, Allan ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Veterinary Medicine   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASMIC DOMAIN OF THE BAND 3 MEMBRANE PROTEIN; GLUTATHIONE; HEMOGLOBIN S; HYPOXANTHINE; MEMBRANE PROTEIN; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME INACTIVATION; ENZYME INHIBITION; ERYTHROCYTE; ERYTHROCYTE FRAGILITY; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OXIDATION; OXIDATIVE STRESS; OXYGENATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SICKLE CELL ANEMIA;

EID: 84876478466     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-414037     Document Type: Article

References (46)

1. Embury SH. The not-so-simple process of sickle cell vasoocclusion. Microcirculation. 2004;11(2):101-113. (Pubitemid 39619073)
2. Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64(1):72-80.
3. Riggs A,Wells M. The oxygen equilibrium of sicklecell hemoglobin. Biochim Biophys Acta. 1961;50: 243-248.
4. Hebbel RP, Morgan WT, Eaton JW, Hedlund BE. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci U S A. 1988;85(1):237-241. (Pubitemid 18055323)
5. Shaklai N, Sharma VS, Ranney HM. Interaction of sickle cell hemoglobin with erythrocyte membranes. Proc Natl Acad Sci U S A. 1981;78(1):65-68. (Pubitemid 11131243)
6. Platt OS, Falcone JF. Membrane protein interactions in sickle red blood cells: evidence of abnormal protein 3 function. Blood. 1995;86(5):1992-1998.
7. Low PS. Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions. Biochim Biophys Acta. 1986;864(2):145-167. (Pubitemid 16027843)
8. Messana I, Orlando M, Cassiano L, et al. Human erythrocyte metabolism is modulated by the O2-linked transition of hemoglobin. FEBS Lett. 1996; 390(1):25-28. (Pubitemid 26233260)
9. Rogers SC, Said A, Corcuera D, McLaughlin D, Kell P, Doctor A. Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance. FASEB J. 2009;23(9):3159-3170.
10. Gibson JS, Cossins AR, Ellory JC. Oxygensensitive membrane transporters in vertebrate red cells. J Exp Biol. 2000;203(Pt 9):1395-1407. (Pubitemid 30351510)
11. Chang SH, Low PS. Regulation of the glycophorin C-rotein 4.1 membrane-To-skeleton bridge and evaluation of its contribution to erythrocyte membrane stability. J Biol Chem. 2001; 276(25):22223-22230.
12. Doctor A, Platt R, Sheram ML, et al. Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients. Proc Natl Acad Sci U S A. 2005;102(16):5709-5714. (Pubitemid 40559624)
13. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409(6820):622-626. (Pubitemid 32154814)
14. Doctor A, Stamler JS. Nitric oxide transport in blood: a third gas in the respiratory cycle. Compr Physiol. 2011;1:611-638.
15. Campanella ME, Chu H, Low PS. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci U S A. 2005;102(7):2402-2407. (Pubitemid 40279388)
16. Lewis IA, Campanella ME, Markley JL, Low PS. Role of band 3 in regulating metabolic flux of red blood cells. Proc Natl Acad Sci U S A. 2009; 106(44):18515-18520.
17. Kinoshita A, Tsukada K, Soga T, et al. Roles of hemoglobin Allostery in hypoxia-induced metabolic alterations in erythrocytes: simulation and its verification by metabolome analysis. J Biol Chem. 2007;282(14):10731-10741. (Pubitemid 47093422)
18. Kuross SA, Rank BH, Hebbel RP. Excess heme in sickle erythrocyte inside-out membranes: possible role in thiol oxidation. Blood. 1988;71(4): 876-882.
19. Waugh SM, Willardson BM, Kannan R, Labotka RJ, Low PS. Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes. J Clin Invest. 1986;78(5):1155-1160. (Pubitemid 17181550)
20. Kannan R, Labotka R, Low PS. Isolation and characterization of the hemachrome-stabilized membrane protein aggregates from sickle erythrocytes. Major site of autologous antibody binding. J Biol Chem. 1988;263(27):13766- 13773.
21. Gizi A, Papassotiriou I, Apostolakou F, et al. Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant-Antioxidant status. Blood Cells Mol Dis. 2011;46(3):220-225.
22. Chu H, Low PS. Mapping of glycolytic enzymebinding sites on human erythrocyte band 3. Biochem J. 2006;400(1):143-151. (Pubitemid 44763829)
23. Endo A, Hasumi K, Sakai K, Kanbe T. Specific inhibition of glyceraldehyde-3-hosphate dehydrogenase by koningic acid (heptelidic acid). J Antibiot. 1985;38(7):920-925. (Pubitemid 15236245)
24. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30(11):1191-1212. (Pubitemid 32463931)
25. Delgado TC, Castro MM, Geraldes CF, Jones JG. Quantitation of erythrocyte pentose pathway flux with [2-13C]glucose and 1H NMR analysis of the lactate methyl signal. Magn Reson Med. 2004; 51(6):1283-1286. (Pubitemid 38797016)
26. Tsai IH, Murthy SN, Steck TL. Effect of red cell membrane binding on the catalytic activity of glyceraldehyde-3-hosphate dehydrogenase. J Biol Chem. 1982;257(3):1438-1442.
27. Dupuy AD, Engelman DM. Protein area occupancy at the center of the red blood cell membrane. Proc Natl Acad Sci U S A. 2008;105(8): 2848-2852. (Pubitemid 351723632)
28. Kaufmann S, Tanaka M. Cell adhesion onto highly curved surfaces: one-step immobilization of human erythrocyte membranes on silica beads. Chemphyschem. 2003;4(7):699-704.
29. Chu H, Breite A, Ciraolo P, Franco RS, Low PS. Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties. Blood. 2008;111(2):932-938.
30. Eaton JW, Brewer GJ. The relationship between red cell 2,3-diphosphoglycerate and levels of hemoglobin in the human. Proc Natl Acad Sci U S A. 1968;61(2):756-760.
31. Rank BH, Carlsson J, Hebbel RP. Abnormal redox status of membrane-rotein thiols in sickle erythrocytes. J Clin Invest. 1985;75(5):1531-1537. (Pubitemid 15041445)
32. Katz J, Wood HG. The use of glucose-C14 for the evaluation of the pathways of glucose metabolism. J Biol Chem. 1960;235:2165-2177.
33. Vasseur C, Leclerc L, Hilly M, Bursaux E. Decreased G3PDH binding to erythrocyte membranes in sickle cell disease. Nouv Rev Fr Hematol. 1992;34(2):155-161.
34. Barbul A, Zipser Y, Nachles A, Korenstein R. Deoxygenation and elevation of intracellular magnesium induce tyrosine phosphorylation of band 3 in human erythrocytes. FEBS Lett. 1999;455(1-2): 87-91. (Pubitemid 29322787)
35. Schrader MC, Simplaceanu V, Ho C. Measurement of fluxes through the pentose phosphate pathway in erythrocytes from individuals with sickle cell anemia by carbon-13 nuclear magnetic resonance spectroscopy. Biochim Biophys Acta. 1993;1182(2):179-188. (Pubitemid 23267041)
36. Darghouth D, Koehl B, Madalinski G, et al. Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome. Blood. 2011; 117(6):e57-e66.
37. Zerez CR, Lachant NA, Lee SJ, Tanaka KR. Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease. Blood. 1988;71(2):512-515. (Pubitemid 18089547)
38. Low PS, Allen DP, Zioncheck TF, et al. Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem. 1987;262(10):4592-4596. (Pubitemid 17102824)
39. Misiti F, Meucci E, Zuppi C, et al. O(2)-dependent stimulation of the pentose phosphate pathway by S-nitrosocysteine in human erythrocytes. Biochem Biophys Res Commun. 2002;294(4):829-834. (Pubitemid 34687191)
40. Siciliano A, Turrini F, Bertoldi M, et al. Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease. Blood Cells Mol Dis. 2010;44(4):233-242.
41. Pawloski JR, Hess DT, Stamler JS. Impaired vasodilation by red blood cells in sickle cell disease. Proc Natl Acad Sci U S A. 2005;102(7):2531-2536. (Pubitemid 40279411)
42. Bernaudin F, Verlhac S, Chevret S, et al. G6PD deficiency, absence of alpha-Thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood. 2008;112(10):4314-4317.
43. Steinberg MH,West MS, Gallagher D, MentzerW. Effects of glucose-6-hosphate dehydrogenase deficiency upon sickle cell anemia. Blood. 1988;71(3): 748-752.
44. Schacter LP. Generation of superoxide anion and hydrogen peroxide by erythrocytes from individuals with sickle trait or normal haemoglobin. Eur J Clin Invest. 1986;16(3):204-210. (Pubitemid 16096134)
45. Souza HP, Liu X, Samouilov A, Kuppusamy P, Laurindo FR, Zweier JL. Quantitation of superoxide generation and substrate utilization by vascular NAD(P)H oxidase. Am J Physiol Heart Circ Physiol. 2002;282(2):H466-474. (Pubitemid 34654969)
46. Bretthorst GL. Bayesian analysis. III. Applications to NMR signal detection, model selection, and parameter estimation. J Mag Res. 1990;88(3): 571-595.